NASDAQ: AVXL
Anavex Life Sciences Corp Stock Ownership - Who owns Anavex Life Sciences?

Insider buying vs selling

Have Anavex Life Sciences Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher U. MisslingPresident and CEO2025-09-11187,500$5.04
$945.00kBuy
Christopher U. MisslingPresident and CEO2025-09-11145,048$9.58
$1.39MSell
Steffen ThomasDirector2025-06-0550,000$1.76
$88.00kBuy
Steffen ThomasDirector2025-06-0511,349$7.75
$87.95kSell
Christopher U. MisslingPresident and CEO2025-03-24500,000$0.92
$460.00kBuy
Christopher U. MisslingPresident and CEO2025-03-24282,497$9.63
$2.72MSell

1 of 1

AVXL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVXL insiders and whales buy or sell their stock.

AVXL Shareholders

What type of owners hold Anavex Life Sciences Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.15%7,001,762$65.61MInstitution
Vanguard Group Inc5.95%5,106,867$47.85MInstitution
State Street Corp3.43%2,948,808$27.63MInstitution
Geode Capital Management LLC2.35%2,019,795$18.93MInstitution
Christopher U. Missling1.76%1,510,165$14.15MInsider
Athanasios Skarpelos1.52%1,306,458$12.24MInsider
Nwam LLC1.19%1,024,479$9.60MInstitution
Two Sigma Investments LP1.13%973,269$9.12MInstitution
George Kalkanis1.05%900,000$8.43MInsider
Invesco Ltd1.01%863,959$8.10MInstitution

1 of 3

AVXL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVXL37.81%5.17%Net BuyingNet Buying
IMNM91.25%7.71%Net BuyingNet Buying
AVBP76.19%23.81%Net BuyingNet Buying
GERN80.63%1.09%Net BuyingNet Buying
PRAX62.65%37.35%Net Selling

Anavex Life Sciences Stock Ownership FAQ

Who owns Anavex Life Sciences?

Anavex Life Sciences (NASDAQ: AVXL) is owned by 37.81% institutional shareholders, 5.17% Anavex Life Sciences insiders, and 57.02% retail investors. Christopher U. Missling is the largest individual Anavex Life Sciences shareholder, owning 1.51M shares representing 1.76% of the company. Christopher U. Missling's Anavex Life Sciences shares are currently valued at $14.15M.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.